“a decreasing trend”

The comparison of clinical, biochemical, and inflammatory parameters between pre- (admission day) and post-Attangaoga-Pranayama practice sessions on the discharge day and post-one and three months showed a decreasing trend and patients attained normal levels by three months; the difference was statistically significant (p<0.05), as depicted in Table 3 .

Results: T1 MCL value showed a decreasing trend with severity of grades (from grade 0 to grade II, p < 0.05), while it increased dramatically at grade III.

CSF inflammatory indexes had a decreasing trend compared with baseline (P>0.05).

There was a decreasing trend in BMP2 (* P <0.05) with the absence of p21.

As the ensiling time progressed, the WSC content exhibited a decreasing trend in all groups ( P < 0.05).

No statistical differences were recorded for SOD and GSH-PX activities, although a decreasing trend was shown in GSH-PX activities by AME treatment ( P > 0.05).

The genotype detection rates of 2v, 4v and 9v showed a decreasing trend with ages (all P < 0.05).

Moreover, the porosities of hydrogel scaffolds with 6%, 8%, and 10% AP content are 82.1% ± 0.4%, 79.7% ± 0.12%, and 75.4% ± 1.3%, respectively, demonstrating a decreasing trend in porosity with increasing AP content ( p < 0.05 ).

SDRs due to ovarian cancer showed a decreasing trend between 2007 and 2021 (APC = −0.5%, p < 0.05).

A decreasing trend was observed in the model group ( P < 0.05), and the increase in body weight of the PaG H group was more pronounced.

The FPG, 2hPG, TG, and ALT showed a decreasing trend at 6 and 12 months of intervention, while the levels of FINS showed an increasing trend, and the control group was lower than the research group ( P < 0.05).

The predicted detection rates showed a decreasing trend toward the end of the year (p>0.05 for all).

The study found that after 6 months of exercise intervention, the L1-L5 segments BMD exhibited a decreasing trend, but the results of paired sample t -test showed that the decrease in BMD of each segment was not significant ( p > 0.05).

The running wheel activities of the rats showed an increase up to four weeks, followed by a decreasing trend after the fourth week ( p < 0.05).

Among them, the α-helix content generally presented a decreasing trend and reached the minimum value of 31.25% in the PAW20s group, which was significantly lower than that in other groups ( p < 0.05).

As shown in Figure 2 D, the solubility of MP in all groups exhibited a decreasing trend with an increasing temperature ( p < 0.05), which was opposite to the trend of surface hydrophobicity.

In winter, the ΔN 2 O concentration, N 2 O saturation and the N 2 O flux of the PRE exhibited a decreasing trend from upstream to downstream, both in surface and bottom waters (Kruskal-Wallis test, P < 0.05, Figs. 2 b, d, f).

Although NLR and PLR levels exhibited an increasing trend, and Ca 2+ levels showed a decreasing trend with greater lesion extent, these differences were not statistically significant ( p > 0.05).

However, there was a decreasing trend in AMPK protein content with 8 μM Rg3 ( P <0.05).

Conversely, height and BMD levels show a decreasing trend in this group ( P < 0.05).

The Cochran-Armitage trend test showed an overall increasing trend in the prevalence of DPN, DPVD, hypertension, DN, CI, lithiasis, DR, DF, and anemia with increasing age ( P < 0.05), while there was a decreasing trend in the prevalence of FL ( P < 0.05).

The branch K/P ratio peaked under the F3 treatment at 120 and 150 days, showing significant increases of 117.5% and 41.9%, respectively, compared to CK ( p < 0.05), but exhibited a decreasing trend by 180 days, with the F4 treatment showing a significant decrease of 37.6% compared to CK ( p < 0.05). 3.4.

Blautia was significantly elevated in BTAC ( P < 0.01), while only a decreasing trend was observed in RT ( P > 0.05).

For ASIR, ASPR, and ASDR of endometriosis, an APC or AAPC > 0 with P < 0.05 indicated a significantly increasing trend, APC or AAPC < 0 with P < 0.05 indicated a decreasing trend, and a 95% CI including 0 with P ≥ 0.05 indicated a stable trend [ 28 , 29 ] .

Conversely, in the Sh-NLRP3, Y and Sh-NLRP3+ Y groups, the expression of NLRP3 and its downstream factors exhibited a decreasing trend ( P < .05), with the Sh-NLRP3 + Y group showing more significant changes ( P < .05), Among them, the expression of NLRP3 and p65 mRNA was reduced in the Sh-NLRP3 + Y group compared with the Sh-NLRP3 and the Y group, but the difference was not statistically significant ( Figure 3A-G ).